GREY:MDCGF - Post by User
Comment by
Probabilityon Nov 18, 2009 8:55am
271 Views
Post# 16498490
RE: RE: Medicago to present at the Influenza Congr
RE: RE: Medicago to present at the Influenza Congr Obviously it is going to be a positive news release on results if they are doing conferences on the process
QUEBEC CITY, Nov. 18 /CNW/ - Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that Frederic Ors, VP Business Development will be presenting at the Influenza Congress USA 2009 on November 20, 2009 at 11:00 am (EST) at The Westin Washington, Washington, D.C. During a session entitled Alternatives to traditional egg-based vaccines, Medicago will discuss its ability to potentially improve the speed, capacity and cost of influenza vaccine production with its proprietary plant-based manufacturing platform and VLP technology.
Influenza Congress USA is an annual influenza conference in North America addressing every aspect of influenza policy and planning, influenza research, development and stakeholder partnerships. The influenza vaccine is the fastest growing segment in the adult vaccine market and the United States accounts for over 50% of the global vaccine market. Annually, more than 3.5 million people die of seasonal influenza. By 2016, this market is expected to grow to $4.4 billion. H1N1 remains the most immediate threat.